Data from EMC - Curated by EPG Health - Last updated 15 August 2016


Calcium Chloride Injection 10% w/v is indicated in the immediate treatment of hypocalcaemic tetany. Other therapy, such as parathyroid hormone and/or vitamin D, may be indicated according to the etiology of the tetany. It is also important to institute oral calcium therapy as soon as practicable.

In cardiac resuscitation, particularly after open heart surgery, calcium chloride has been used when adrenaline has failed to improve weak or ineffective myocardial contractions.

Calcium salts have been used as adjunctive therapy in a number of conditions, including the following:

1. In severe hyperkalaemia, calcium may be injected slowly while the ECG is monitoring the heart.

2. As an aid in the treatment of depression due to overdosage of magnesium sulphate (calcium is the antagonist of magnesium toxicity).

Routes of administration:

For intracardiac or slow intravenous use only.


Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cardiovascular Metabolism Knowledge Centre

Cardiovascular Metabolism Knowledge Centre

The Cardiovascular Metabolism Knowledge Centre is an information hub providing expert insight into the management of hypertension and type 2 diabetes. This Knowledge Centre contains a wealth of scientific video content offering insights and opinion from some of the leading experts in the field.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder International Medication Systems (UK) Limited